In re Buspirone Antitrust Litigation
MDL Docket No. 1410 (S.D.N.Y., Hon. John G. Koeltl.)


Challenging Bristol-Myers Squibb's alleged unlawful acts to prevent the marketing and sale of a generic version of busiprone hydrocholoride.

Garwin, Bronzaft, Gerstein & Fisher, L.L.P. is co-lead counsel in this case.